COVID-19 vaccine counseling and safety assessment in children and teenagers with underlying medical conditions in China: a single center study

References

• Imamura T, Saito M, Ko YK, Imamura T, Otani K, Akaba H, Ninomiya K, Furuse Y, Miyahara R, Sando E, et al. Roles of children and adolescents in COVID-19 transmission in the community: a retrospective analysis of nationwide data in Japan. Front Pediatr. 2021;9:1. doi:10.3389/fped.2021.705882.
   Web of Science ®Google Scholar
• Pediatrics AAo. Children and COVID-19: state-level data report 2022 [accessed 2022 Jan 24]. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/.
   Google Scholar
• Organization WH. Coronavirus disease (COVID-19): vaccines 2021 [accessed 2021 Nov 29]. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines.
   Google Scholar
• Administration USFaD. FDA approves first COVID-19 vaccine 2021 [accessed 2021 Aug 23]. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.
   Google Scholar
• China NHCo. State Council Joint Prevention and Control Mechanism Press Conference on December 20, 2021; 2021. http://www.nhc.gov.cn/xcs/yqfkdt/202112/bb163e5e345546669130c0a894a91ca1.shtml.
   Google Scholar
• Alfieri NL, Kusma JD, Heard-Garris N, Davis MM, Golbeck E, Barrera L, Macy ML. Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot. BMC Public Health. 2021 Sep 13;21(1):1662. doi:10.1186/s12889-021-11725-5.
   PubMed Web of Science ®Google Scholar
• Bagateli LE, Saeki EY, Fadda M, Agostoni C, Marchisio P, Milani GP. COVID-19 vaccine hesitancy among parents of children and adolescents living in Brazil. Vaccines (Basel). 2021 Sep 30;9(10). doi:10.3390/vaccines9101115.
   PubMed Web of Science ®Google Scholar
• Yigit M, Ozkaya-Parlakay A, Senel E. Evaluation of COVID-19 vaccine refusal in parents. Pediatr Infect Dis J. 2021 Apr 1;40(4):e134–8. doi:10.1097/INF.0000000000003042.
   PubMed Web of Science ®Google Scholar
• Skeens M, Guttoo P, Stanek JR, Taylor K, Stratz E, Ardura MI, Rangarajan HG. An exploration of COVID-19 impact and vaccine hesitancy in parents of pediatric Hematopoietic Stem Cell Transplant (HCT) recipients. Bone Marrow Transplant. 2022 Jan 24;57(4):547–553. doi:10.1038/s41409-022-01587-9.
   PubMed Web of Science ®Google Scholar
• Tsai R, Hervey J, Hoffman K, Wood J, Johnson J, Deighton D, Clermont D, Loew B, Goldberg SL. COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: cross-sectional, internet-based survey. JMIR Public Health Surveill. 2022 Jan 5;8(1):e29872. doi:10.2196/29872.
   PubMedGoogle Scholar
• Waters AR, Kepka D, Ramsay JM, Mann K, Vaca Lopez PL, Anderson JS, Ou JY, Kaddas HK, Palmer A, Ray N, et al. COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors. JNCI Cancer Spectr. 2021;5(3):kab049. doi:10.1093/jncics/pkab049.
   Web of Science ®Google Scholar
• Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(12):1645–1653. doi:10.1016/S1473-3099(21)00319-4.
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect Dis. 2022;22(2):196–208. doi:10.1016/S1473-3099(21)00462-X.
   PubMed Web of Science ®Google Scholar
• China NHCo. Practical guideline of COVID-19 vaccination (First Edition) 2021 [accessed 2021 Mar 29]. http://www.nhc.gov.cn/jkj/s3582/202103/c2febfd04fc5498f916b1be080905771.shtml.
   Google Scholar
• Moreno MA. Atopic diseases in children. JAMA Pediatr. 2016;170(1):96. doi:10.1001/jamapediatrics.2015.3886.
   PubMed Web of Science ®Google Scholar
• Nilsson L, Brockow K, Alm J, Cardona V, Caubet J-C, Gomes E, Jenmalm MC, Lau S, Netterlid E, Schwarze J, et al. Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol. 2017;28(7):628–640. doi:10.1111/pai.12762.
   PubMed Web of Science ®Google Scholar
• Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet J-C, Engler RJM, Gold MS, Ponvert C, et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J. 2016;9(1):32. doi:10.1186/s40413-016-0120-5.
   PubMed Web of Science ®Google Scholar
• Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. Jama. 2021;326(14):1390–1399. doi:10.1001/jama.2021.15072.
   PubMed Web of Science ®Google Scholar
• McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, Hambidge SJ, Lee GM, Jackson LA, Irving SA, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868–878. doi:10.1016/j.jaci.2015.07.048.
   PubMed Web of Science ®Google Scholar
• American Academy of Allergy A, and Immunology. Vaccine reactions. 2022.
   Google Scholar
• Prevention USCfDCa. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States 2021 [accessed 2021 Nov 3]. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html.
   Google Scholar
• Sokolowska M, Eiwegger T, Ollert M, Torres MJ, Barber D, Del Giacco S, Jutel M, Nadeau KC, Palomares O, Rabin RL, et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Allergy. 2021;76(6):1629–1639. doi:10.1111/all.14739.
   PubMed Web of Science ®Google Scholar
• Welfare IMoHaF. Who will get the vaccine? 2021 [accessed 25 Mar 2021]. https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs.html#who-will-get-the-vaccine.
   Google Scholar
• Richter D, Anca I, André FE, Bakir M, Chlibek R, Čižman M, Mangarov A, Mészner Z, Pokorn M, Prymula R, et al. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations. Expert Rev Vaccines. 2014;13(6):801–815. doi:10.1586/14760584.2014.897615.
   PubMed Web of Science ®Google Scholar
• Li N, Chu C, Lin W. A survey of hesitancy and response to the COVID-19 vaccine among patients with epilepsy in Northeast China. Front Neurol. 2021;12:778618. doi:10.3389/fneur.2021.778618.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang Q, Xiao J, Zhang Y, Peng W, Han X, Chen S, Yang D, Sander JW, Zhou D, et al. COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China. Epilepsia. 2022;63(1):244–251. doi:10.1111/epi.17138.
   PubMed Web of Science ®Google Scholar
• Massoud F, Ahmad SF, Hassan AM, Alexander KJ, Al–hashel J, Arabi M. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): a cross-sectional study. Seizure. 2021;92:2–9. doi:10.1016/j.seizure.2021.08.001.
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Sahraian A, Badv RS, Sahraian MA. Physicians’ opinions on the necessity of COVID-19 vaccination in patients with epilepsy. Epileptic Disord. 2021 Jun 1;23(3):485–489. doi:10.1684/epd.2021.1282.
   PubMed Web of Science ®Google Scholar